Allmed Medical Products Co.,Ltd (SHE:002950)
China · Delayed Price · Currency is CNY 9.82
+0.89 (9.97%)
Jun 18, 2026, 3:04 PM CST
SHE:002950 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 5,496 | 6,757 | 5,419 | 6,003 | 7,758 | 10,354 | |
Market Cap Growth | 0.93% | 24.69% | -9.73% | -22.61% | -25.08% | -19.50% |
Enterprise Value | 5,774 | 6,402 | 5,590 | 6,190 | 8,709 | 11,541 |
Last Close Price | 8.93 | 10.92 | 8.67 | 9.38 | 12.05 | 15.81 |
PE Ratio | 20.22 | 27.15 | 14.70 | 54.38 | 19.07 | 24.01 |
Forward PE | - | 10.45 | 10.45 | 10.45 | 10.45 | 10.45 |
PS Ratio | 1.44 | 1.84 | 1.63 | 2.18 | 1.84 | 3.54 |
PB Ratio | 1.48 | 1.87 | 1.57 | 1.87 | 2.48 | 3.76 |
P/TBV Ratio | 1.63 | 2.07 | 1.72 | 2.08 | 2.78 | 4.15 |
P/FCF Ratio | 19.23 | 14.79 | 9.77 | 43.81 | 10.32 | 123.03 |
P/OCF Ratio | 9.60 | 9.42 | 7.62 | 14.18 | 6.75 | 27.62 |
EV/Sales Ratio | 1.52 | 1.74 | 1.68 | 2.25 | 2.07 | 3.95 |
EV/EBITDA Ratio | 6.80 | 7.97 | 8.49 | 15.34 | 8.64 | 21.66 |
EV/EBIT Ratio | 9.44 | 11.18 | 12.89 | 34.50 | 10.67 | 29.77 |
EV/FCF Ratio | 20.20 | 14.01 | 10.08 | 45.18 | 11.59 | 137.13 |
Debt / Equity Ratio | 0.28 | 0.22 | 0.19 | 0.30 | 0.30 | 0.47 |
Debt / EBITDA Ratio | 1.21 | 1.00 | 1.00 | 2.36 | 0.93 | 2.41 |
Debt / FCF Ratio | 3.58 | 1.77 | 1.19 | 7.01 | 1.25 | 15.32 |
Net Debt / Equity Ratio | 0.07 | -0.05 | 0.00 | 0.14 | 0.05 | 0.22 |
Net Debt / EBITDA Ratio | 0.30 | -0.20 | -0.01 | 1.15 | 0.15 | 1.13 |
Net Debt / FCF Ratio | 0.89 | -0.36 | -0.01 | 3.39 | 0.20 | 7.16 |
Asset Turnover | 0.68 | 0.69 | 0.66 | 0.51 | 0.78 | 0.59 |
Inventory Turnover | 3.78 | 3.90 | 3.63 | 2.65 | 3.26 | 2.64 |
Quick Ratio | 1.09 | 1.19 | 1.11 | 0.72 | 0.66 | 0.78 |
Current Ratio | 1.85 | 1.81 | 1.74 | 1.34 | 1.16 | 1.37 |
Return on Equity (ROE) | 7.83% | 7.28% | 11.08% | 3.29% | 13.76% | 15.22% |
Return on Assets (ROA) | 6.87% | 6.71% | 5.34% | 2.07% | 9.49% | 4.91% |
Return on Invested Capital (ROIC) | 14.20% | 13.83% | 9.89% | 3.18% | 20.52% | 11.18% |
Return on Capital Employed (ROCE) | 13.20% | 13.40% | 11.00% | 4.80% | 22.20% | 11.50% |
Earnings Yield | 4.94% | 3.68% | 6.80% | 1.84% | 5.24% | 4.17% |
FCF Yield | 5.20% | 6.76% | 10.23% | 2.28% | 9.69% | 0.81% |
Dividend Yield | 1.63% | 1.34% | 0.69% | 0.29% | 0.50% | 1.33% |
Payout Ratio | 19.13% | 21.03% | 11.96% | 59.07% | 40.29% | 133.84% |
Buyback Yield / Dilution | 1.69% | 0.99% | 1.33% | -0.02% | -0.17% | 0.05% |
Total Shareholder Return | 3.28% | 2.33% | 2.02% | 0.26% | 0.33% | 1.38% |